Search Results - "Speer, B. Bryce"
-
1
Inpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients
Published in Annals of surgical oncology (01-10-2019)“…Background Despite advances in enhanced surgical recovery programs, strategies limiting postoperative inpatient opioid exposure have not been optimized for…”
Get full text
Journal Article -
2
Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapy
Published in Journal of surgical oncology (01-12-2021)“…Background and Objectives The impact of perioperative blood transfusion (PBT) on outcomes for pancreatic ductal adenocarcinoma (PDAC) patients given…”
Get full text
Journal Article -
3
Accelerated enhanced Recovery following Minimally Invasive colorectal cancer surgery (RecoverMI): a study protocol for a novel randomised controlled trial
Published in BMJ open (20-07-2017)“…IntroductionDefinitive treatment of localised colorectal cancer involves surgical resection of the primary tumour. Short-stay colectomies (eg, 23-hours) would…”
Get full text
Journal Article -
4
Accelerated enhanced Recover y following M inimally I nvasive colorectal cancer surgery ( RecoverMI ): a study protocol for a novel randomised controlled trial
Published in BMJ open (01-08-2017)“…Definitive treatment of localised colorectal cancer involves surgical resection of the primary tumour. Short-stay colectomies (eg, 23-hours) would have…”
Get full text
Journal Article -
5
Advance electronic screening of patients with cancer leveraging a new EHR to increase efficiency of care delivery, driving clinical care pathways in a perioperative anesthesia assessment center (PAAC), at a comprehensive cancer center
Published in Journal of clinical oncology (20-10-2018)“…Abstract only 308 Background: Most cancer institutions are using electronic health records (EHRs). With MACRA and MIPS, this number will continue to grow…”
Get full text
Journal Article -
6
A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients
Published in Surgery open science (01-07-2022)“…We designed a prospective feasibility study to assess the 5x-multiplier (5x) calculation (eg, 3 pills in last 24 hours × 5 = 15) to standardize discharge…”
Get full text
Journal Article